- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/54 - Spiro-condensed
Patent holdings for IPC class C07D 209/54
Total number of patents in this class: 205
10-year publication summary
|
17
|
15
|
26
|
12
|
15
|
14
|
16
|
11
|
13
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3501 |
15 |
| Bayer Cropscience AG | 1844 |
15 |
| VALO Health, Inc. | 193 |
8 |
| KYORIN Pharmaceutical Co., Ltd. | 162 |
7 |
| F. Hoffmann-La Roche AG | 7837 |
6 |
| Pfizer Inc. | 3386 |
6 |
| Takeda Pharmaceutical Company Limited | 2712 |
6 |
| KBP Biosciences Co., Ltd. | 29 |
6 |
| Bayer Intellectual Property GmbH | 2364 |
5 |
| Wuhan Createrna Science and Technology Co.,Ltd. | 36 |
5 |
| Syngenta Crop Protection AG | 6701 |
4 |
| Korea Advanced Institute of Science and Technology | 4664 |
4 |
| Institute for Basic Science | 384 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Cytokinetics, Inc. | 251 |
3 |
| Hong Kong Baptist University | 119 |
3 |
| Merck Sharp & Dohme LLC | 3734 |
3 |
| Glaxo Group Limited | 4375 |
2 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Hoffmann-La Roche Inc. | 3793 |
2 |
| Other owners | 96 |